137 related articles for article (PubMed ID: 8770297)
1. Prevention of murine breast cancer by vaccination with tumor cells modified by cytokine-producing recombinant vaccinia viruses.
Peplinski GR; Tsung K; Meko JB; Norton JA
Ann Surg Oncol; 1996 Jan; 3(1):15-23. PubMed ID: 8770297
[TBL] [Abstract][Full Text] [Related]
2. Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 beta.
Peplinski GR; Tsung K; Whitman ED; Meko JB; Norton JA
Ann Surg Oncol; 1995 Mar; 2(2):151-9. PubMed ID: 7728569
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production and antitumor effect of a nonreplicating, noncytopathic recombinant vaccinia virus expressing interleukin-12.
Meko JB; Tsung K; Norton JA
Surgery; 1996 Aug; 120(2):274-82; discussion 282-3. PubMed ID: 8751593
[TBL] [Abstract][Full Text] [Related]
4. Immunization with a syngeneic tumor infected with recombinant vaccinia virus expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) induces tumor regression and long-lasting systemic immunity.
McLaughlin JP; Abrams S; Kantor J; Dobrzanski MJ; Greenbaum J; Schlom J; Greiner JW
J Immunother; 1997 Nov; 20(6):449-59. PubMed ID: 9409450
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
[TBL] [Abstract][Full Text] [Related]
6. In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1beta.
Peplinski GR; Tsung AK; Casey MJ; Meko JB; Fredrickson TN; Buller RM; Norton JA
Cancer J Sci Am; 1996; 2(1):21-7. PubMed ID: 9166494
[TBL] [Abstract][Full Text] [Related]
7. The effect of T1 and T2 cytokines on the cytotoxic T cell response to mannan-MUC1.
Lees CJ; Apostolopoulos V; Acres B; Ong CS; Popovski V; McKenzie IF
Cancer Immunol Immunother; 2000 Feb; 48(11):644-52. PubMed ID: 10663612
[TBL] [Abstract][Full Text] [Related]
8. Construction of recombinant vaccinia virus expressing GM-CSF and its use as tumor vaccine.
Qin HX; Chatterjee SK
Gene Ther; 1996 Jan; 3(1):59-66. PubMed ID: 8929912
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses.
Griffith TS; Kawakita M; Tian J; Ritchey J; Tartaglia J; Sehgal I; Thompson TC; Zhao W; Ratliff TL
J Natl Cancer Inst; 2001 Jul; 93(13):998-1007. PubMed ID: 11438565
[TBL] [Abstract][Full Text] [Related]
10. Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.
Kawakita M; Rao GS; Ritchey JK; Ornstein DK; Hudson MA; Tartaglia J; Paoletti E; Humphrey PA; Harmon TJ; Ratliff TL
J Natl Cancer Inst; 1997 Mar; 89(6):428-36. PubMed ID: 9091644
[TBL] [Abstract][Full Text] [Related]
11. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
[TBL] [Abstract][Full Text] [Related]
12. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.
Wakimoto H; Abe J; Tsunoda R; Aoyagi M; Hirakawa K; Hamada H
Cancer Res; 1996 Apr; 56(8):1828-33. PubMed ID: 8620500
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.
Sampson JH; Archer GE; Ashley DM; Fuchs HE; Hale LP; Dranoff G; Bigner DD
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10399-404. PubMed ID: 8816812
[TBL] [Abstract][Full Text] [Related]
14. In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta.
Peplinski GR; Tsung K; Meko JB; Norton JA
Surgery; 1995 Aug; 118(2):185-90; discussion 190-1. PubMed ID: 7638732
[TBL] [Abstract][Full Text] [Related]
15. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing.
Inoue T; Byrne T; Inoue M; Tait ME; Wall P; Wang A; Dermyer MR; Laklai H; Binder JJ; Lees C; Hollingsworth R; Maruri-Avidal L; Kirn DH; McDonald DM
Mol Cancer Ther; 2021 Aug; 20(8):1481-1494. PubMed ID: 34045231
[TBL] [Abstract][Full Text] [Related]
17. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
18. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.
Aarts WM; Schlom J; Hodge JW
Cancer Res; 2002 Oct; 62(20):5770-7. PubMed ID: 12384537
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
Deng L; Fan J; Guo M; Huang B
Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
[TBL] [Abstract][Full Text] [Related]
20. Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice.
Sivanandham M; Shaw P; Bernik SF; Paoletti E; Wallack MK
Cancer Immunol Immunother; 1998 Jul; 46(5):261-7. PubMed ID: 9690454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
